Healthtech acquisition creates market leader
Healthtech company Isopharm has been acquired by compliance platform, CODE.
The Sheffield-based business is the leading provider of online CPD for the dental market using innovative solutions to meet the mandatory requirements for continuous development. The business also provides software and services for validation and testing to a broad range of healthcare providers.
The deal is the result of four years of dialogue between Isopharm and CODE’s investors, London-based August Equity. It also marks the start of the business’ expansion into adjacent healthcare market verticals, creating the market leader in dental compliance.
Andrew Kemp, founder of Isopharm said: “CODE is the perfect platform for the next stage of innovative solutions we had planned; we are delighted to be joining forces”.
James Bakewell, director (August Equity and CODE) added: “We are thrilled to have been able to unite CODE and Isopharm to create a highly unique and strategic compliance-focussed business in a market that offers significant opportunity. The combination of software-led compliance solutions and online training to the healthcare market is exciting – a market that’s undergoing a technology-focussed structural shift. We are extremely excited about combining the businesses and working closely with Andrew and the team at Isopharm”.
Isopharm was advised on the deal Paul Johnson, partner and principal associate Vicky Protano of Mills & Reeve
CODE was advised by Paul Mann, partner and associates Guy Ruddy and Nathan Bentley of Squire Paton Boggs, alongside 8Advisory (Financial), PwC (Commercial), and CMS (Legal).
